200 related articles for article (PubMed ID: 16799074)
1. Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease.
Hurst JR; Donaldson GC; Perera WR; Wilkinson TM; Bilello JA; Hagan GW; Vessey RS; Wedzicha JA
Am J Respir Crit Care Med; 2006 Oct; 174(8):867-74. PubMed ID: 16799074
[TBL] [Abstract][Full Text] [Related]
2. Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers.
Bafadhel M; McKenna S; Terry S; Mistry V; Reid C; Haldar P; McCormick M; Haldar K; Kebadze T; Duvoix A; Lindblad K; Patel H; Rugman P; Dodson P; Jenkins M; Saunders M; Newbold P; Green RH; Venge P; Lomas DA; Barer MR; Johnston SL; Pavord ID; Brightling CE
Am J Respir Crit Care Med; 2011 Sep; 184(6):662-71. PubMed ID: 21680942
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory changes, recovery and recurrence at COPD exacerbation.
Perera WR; Hurst JR; Wilkinson TM; Sapsford RJ; Müllerova H; Donaldson GC; Wedzicha JA
Eur Respir J; 2007 Mar; 29(3):527-34. PubMed ID: 17107990
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility to exacerbation in chronic obstructive pulmonary disease.
Hurst JR; Vestbo J; Anzueto A; Locantore N; Müllerova H; Tal-Singer R; Miller B; Lomas DA; Agusti A; Macnee W; Calverley P; Rennard S; Wouters EF; Wedzicha JA;
N Engl J Med; 2010 Sep; 363(12):1128-38. PubMed ID: 20843247
[TBL] [Abstract][Full Text] [Related]
6. Systemic inflammation in chronic obstructive pulmonary disease: the role of exacerbations.
Wouters EF; Groenewegen KH; Dentener MA; Vernooy JH
Proc Am Thorac Soc; 2007 Dec; 4(8):626-34. PubMed ID: 18073394
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with change in exacerbation frequency in COPD.
Donaldson GC; Müllerova H; Locantore N; Hurst JR; Calverley PM; Vestbo J; Anzueto A; Wedzicha JA
Respir Res; 2013 Jul; 14(1):79. PubMed ID: 23899210
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease.
Barnes PJ
J Allergy Clin Immunol; 2016 Jul; 138(1):16-27. PubMed ID: 27373322
[TBL] [Abstract][Full Text] [Related]
9. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019.
Singh D; Agusti A; Anzueto A; Barnes PJ; Bourbeau J; Celli BR; Criner GJ; Frith P; Halpin DMG; Han M; López Varela MV; Martinez F; Montes de Oca M; Papi A; Pavord ID; Roche N; Sin DD; Stockley R; Vestbo J; Wedzicha JA; Vogelmeier C
Eur Respir J; 2019 May; 53(5):. PubMed ID: 30846476
[TBL] [Abstract][Full Text] [Related]
10. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary.
Vogelmeier CF; Criner GJ; Martinez FJ; Anzueto A; Barnes PJ; Bourbeau J; Celli BR; Chen R; Decramer M; Fabbri LM; Frith P; Halpin DM; López Varela MV; Nishimura M; Roche N; Rodriguez-Roisin R; Sin DD; Singh D; Stockley R; Vestbo J; Wedzicha JA; Agustí A
Am J Respir Crit Care Med; 2017 Mar; 195(5):557-582. PubMed ID: 28128970
[TBL] [Abstract][Full Text] [Related]
11. Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype.
Agustí A; Edwards LD; Rennard SI; MacNee W; Tal-Singer R; Miller BE; Vestbo J; Lomas DA; Calverley PM; Wouters E; Crim C; Yates JC; Silverman EK; Coxson HO; Bakke P; Mayer RJ; Celli B;
PLoS One; 2012; 7(5):e37483. PubMed ID: 22624038
[TBL] [Abstract][Full Text] [Related]
12. Copeptin, C-reactive protein, and procalcitonin as prognostic biomarkers in acute exacerbation of COPD.
Stolz D; Christ-Crain M; Morgenthaler NG; Leuppi J; Miedinger D; Bingisser R; Müller C; Struck J; Müller B; Tamm M
Chest; 2007 Apr; 131(4):1058-67. PubMed ID: 17426210
[TBL] [Abstract][Full Text] [Related]
13. Implementation of the Care Bundle for the Management of Chronic Obstructive Pulmonary Disease with/without Heart Failure.
Bianco A; Canepa M; Catapano GA; Marvisi M; Oliva F; Passantino A; Sarzani R; Tarsia P; Versace AG
J Clin Med; 2024 Mar; 13(6):. PubMed ID: 38541845
[TBL] [Abstract][Full Text] [Related]
14. COPD: systemic proteomic profiles in frequent and infrequent exacerbators.
Enríquez-Rodríguez CJ; Casadevall C; Faner R; Castro-Costa A; Pascual-Guàrdia S; Seijó L; López-Campos JL; Peces-Barba G; Monsó E; Barreiro E; Cosío BG; Agustí A; Gea J;
ERJ Open Res; 2024 Mar; 10(2):. PubMed ID: 38529348
[TBL] [Abstract][Full Text] [Related]
15. Plasmonic Alloys Enhanced Metabolic Fingerprints for the Diagnosis of COPD and Exacerbations.
Su H; Song Y; Yang S; Zhang Z; Shen Y; Yu L; Chen S; Gao L; Chen C; Hou D; Wei X; Ma X; Huang P; Sun D; Zhou J; Qian K
ACS Cent Sci; 2024 Feb; 10(2):331-343. PubMed ID: 38435520
[TBL] [Abstract][Full Text] [Related]
16. Identification and Characterization of a ceRNA Regulatory Network Involving LINC00482 and PRRC2B in Peripheral Blood Mononuclear Cells: Implications for COPD Pathogenesis and Diagnosis.
Huang W; Luo T; Lan M; Zhou W; Zhang M; Wu L; Lu Z; Fan L
Int J Chron Obstruct Pulmon Dis; 2024; 19():419-430. PubMed ID: 38348310
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of alpha-1 antitrypsin deficiency related lung disease exacerbations using a daily symptom diary and urinary biomarkers.
Ellis P; Parekh G; Duvoix A; Watson L; Sharp A; Mobeen F; Pye A; Stockley R; Turner A
PLoS One; 2024; 19(2):e0297125. PubMed ID: 38306339
[TBL] [Abstract][Full Text] [Related]
18. Validation of the Rome Severity Classification of Chronic Obstructive Pulmonary Disease Exacerbation: A Multicenter Cohort Study.
Zeng J; Zhou C; Yi Q; Luo Y; Wei H; Ge H; Liu H; Zhang J; Li X; Pan P; Yi M; Cheng L; Liu L; Zhang J; Peng L; Pu J; Zhou H;
Int J Chron Obstruct Pulmon Dis; 2024; 19():193-204. PubMed ID: 38249828
[TBL] [Abstract][Full Text] [Related]
19. Periodontopathogens
Shi T; Wang J; Dong J; Hu P; Guo Q
Pathogens; 2023 Aug; 12(9):. PubMed ID: 37764918
[TBL] [Abstract][Full Text] [Related]
20. Peripheral Blood Eosinophilia and Neutrophil Lymphocyte Ratio in the Choice of Antibiotic and/or Steroid in Patients Hospitalized with Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
Köse Kabil N; Karakurt Z; Gündoğuş B; Güngör A; Akyüz K; Türker H
Thorac Res Pract; 2023 Jul; 24(4):220-227. PubMed ID: 37485712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
